Immunolabeling of skin biopsy specimens revealed that MARCO expression colocalized with CD68+ myeloid cells, which were significantly (P < 0.05) enriched in patients with SSc compared with controls (Supplemental Figure 1, B and C). The gene discussed is MARCO; the disease is systemic sclerosis.